Zobrazeno 1 - 10
of 44
pro vyhledávání: '"H. Chih-Ho Hong"'
Autor:
April W. Armstrong, H. Chih-Ho Hong, Brian M. Calimlim, Marric G. Buessing, Marjorie M. Crowell, Jonathan I. Silverberg
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 9, Pp 2457-2465 (2024)
Abstract Introduction Efficacy of upadacitinib has been assessed in trials including Measure Up 1 (NCT03569293), Measure Up 2 (NCT03607422), and Heads Up (NCT03738397). Measure Up 1 and 2 assessed efficacy of upadacitinib 30 mg and upadacitinib 15 mg
Externí odkaz:
https://doaj.org/article/c50f79e2bc6f4b5e8459d5588f42735c
Autor:
Eric L. Simpson, Marjolein de Bruin-Weller, H. Chih-ho Hong, Delphine Staumont-Sallé, Andrew Blauvelt, Kilian Eyerich, Melinda Gooderham, Mona Shahriari, Lotus Mallbris, Amber Reck Atwater, Maria Jose Rueda, Yuxin Ding, Zhuqing Liu, Helena Agell, Jonathan I. Silverberg
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 5, Pp 1145-1160 (2024)
Abstract Introduction Atopic dermatitis (AD) affects multiple areas of the body, some of which may be more refractory to treatment. We evaluated improvements in the Eczema Area and Severity Index (EASI) by body region and clinical signs for each body
Externí odkaz:
https://doaj.org/article/837994b491e148fd89376ffe68c7f997
Autor:
Adelaide A. Hebert, Carsten Flohr, H. Chih-ho Hong, Alan D. Irvine, Evangeline Pierce, Hany Elmaraghy, Sreekumar Pillai, Zach Dawson, Sherry Chen, Clara Armengol, Elaine Siegfried, Stephan Weidinger
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
AbstractBackground Lebrikizumab, a high-affinity monoclonal antibody targeting IL-13, previously demonstrated clinical efficacy in three randomized, double-blind, placebo-controlled Phase 3 trials that included adults and adolescents with moderate-to
Externí odkaz:
https://doaj.org/article/b5ef1bb85af14e1fb68d15d4099d7b35
Autor:
Melinda Gooderham, Ronald Vender, Jeffrey Crowley, H. Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, Lawrence Green
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 2, Pp 441-451 (2024)
Abstract Introduction When assessing the effect of a therapy for psoriasis (PsO), it is important to consider speed of response and cumulative response. However, responses among biologics may differ by body regions. This post hoc analysis compares sp
Externí odkaz:
https://doaj.org/article/f00c3bb6c4ff40e9a728bb090f968f07
Autor:
Jonathan I. Silverberg, H. Chih-ho Hong, Brian M. Calimlim, Wan-Ju Lee, Henrique D. Teixeira, Eric B. Collins, Marjorie M. Crowell, Scott J. Johnson, April W. Armstrong
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 10, Pp 2247-2264 (2023)
Abstract Introduction The treatment landscape for moderate-to-severe atopic dermatitis (AD) continues to expand. This network meta-analysis (NMA) updates a previously conducted NMA to include data from the most recent phase 3 trials to assess the com
Externí odkaz:
https://doaj.org/article/a652da315a6b45c186f4bac0bdfe50c5
Autor:
Michelle Le, Melissa Berman-Rosa, Feras M. Ghazawi, Marc Bourcier, Loretta Fiorillo, Melinda Gooderham, Lyn Guenther, Sameh Hanna, H. Chih-Ho Hong, Ian Landells, Perla Lansang, Danielle Marcoux, Marni C. Wiseman, Jensen Yeung, Charles Lynde, Ivan V. Litvinov
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Atopic dermatitis is a chronic, relapsing and remitting disease that can be difficult to treat despite a recently approved biologic therapy targeting IL-4/IL-13 receptor. Oral janus kinase inhibitors (JAKi) represent a novel therapeutic c
Externí odkaz:
https://doaj.org/article/f52d9dc4eec44b8d8da97803c35cd761
Autor:
Amy S. Paller, Carsten Flohr, Michael Cork, Anthony Bewley, Andrew Blauvelt, H. Chih-ho Hong, Shinichi Imafuku, Marie L. A. Schuttelaar, Eric L. Simpson, Weily Soong, Petra Arlert, Katja Wendicke Lophaven, Azra Kurbasic, Lise Soldbro, Natacha Strange Vest, Andreas Wollenberg
Publikováno v:
Jama dermatology. 159(6):596-605
ImportanceSafe and effective long-term treatments for adolescents with moderate to severe atopic dermatitis (AD) are limited.ObjectiveTo evaluate the efficacy and safety of interleukin-13–targeted treatment with tralokinumab monotherapy in adolesce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb3d2a62eddd1df0fcc9406f56dbc502
https://doi.org/10.1001/jamadermatol.2023.0627
https://doi.org/10.1001/jamadermatol.2023.0627
Autor:
Zoe D Draelos, David N Adam, H Chih-ho Hong, Mark G Lebwohl, Charles W Lynde, Walter K Nahm, Kim A Papp, David M Pariser, Linda Stein Gold, Daniel Stewart, Robert C Higham, David R Berk, David Krupa, Patrick Burnett
Publikováno v:
British Journal of Dermatology. 188:810-812
This post hoc analysis evaluated efficacy and safety of roflumilast cream in patients with psoriasis involving the face/neck or intertriginous areas from a phase IIb trial. Of 331 patients enrolled in the phase IIb trial, 160 had psoriasis involving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31b6566569b004a78c9b5ea14a9890b8
https://doi.org/10.1093/bjd/ljad060
https://doi.org/10.1093/bjd/ljad060
Autor:
Kristian Reich, Jacob P Thyssen, Andrew Blauvelt, Kilian Eyerich, Weily Soong, Zakiya P Rice, H Chih-ho Hong, Norito Katoh, Fernando Valenzuela, Marco DiBonaventura, Tamara A Bratt, Fan Zhang, Claire Clibborn, Ricardo Rojo, Hernan Valdez, Urs Kerkmann
Publikováno v:
The Lancet. 400:273-282
Phase 3 trials have assessed efficacy of abrocitinib versus placebo in moderate-to-severe atopic dermatitis, a common immunoinflammatory skin disease. This study assessed the efficacy and safety of abrocitinib versus dupilumab.This randomised, double
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4827c46dae50e0bbd8b6782cae603c4
https://doi.org/10.1016/s0140-6736(22)01199-0
https://doi.org/10.1016/s0140-6736(22)01199-0
Autor:
Kristian Reich, Jacob P. Thyssen, Andrew Blauvelt, Kilian Eyerich, Weily Soong, Zakiya P. Rice, H. Chih-ho Hong, Norito Katoh, Fernando Valenzuela, Marco DiBonaventura, Tamara A. Bratt, Fan Zhang, Claire Clibborn, Ricardo Rojo, Hernan Valdez, Urs Kerkmann
Publikováno v:
Immunotherapy.
What is this summary about? Atopic dermatitis (AD, also called atopic eczema) is a skin disease that that can affect a person for a long time and causes red or flaky skin that can be itchy and uncomfortable. Healthcare providers can prescribe medicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7efc831a7ba94772d2a0ece8e2a4c3b
https://doi.org/10.2217/imt-2022-0306
https://doi.org/10.2217/imt-2022-0306